The drug is intended for adolescents and children who weigh more than 15 kg.
Erdomed is a mucolytic that, after oral administration, reduces the viscosity of bronchial secretions and promotes their elimination, improving respiration.
Erdomed is used as a pectolytic therapy in acute and chronic bronchitis, associated with impaired mucus production and transport, and for thinning of viscous mucus in acute and chronic airway disorders.
The active ingredient of domed
- The active substance is endosteum.
Erdomed comes in a blister pack of 300 mg capsules and vials.
Its excipients are microcrystalline cellulose, povidone, magnesium stearate, capsule, gelatin, titanium dioxide (E 171), yellow iron oxide (E172), erythrosine (E127), indigotin (E132).
- Treatment of bronchial secretion disorders, favoring the thinning of the mucus and mucopurulent secretions or expectoration.
- Acute and chronic lung disorders (exacerbations passing or stable bronchitis, acute and chronic bronchiectasis, asthma, bronchial hypersecretion)
- The upper respiratory tract’s acute and chronic disorders (rhinitis, sinusitis, pharyngitis, laryngitis, tracheitis).
Hypersecretory of lung diseases such as:
- Pulmonary emphysema.
- Chronic bronchitis in smokers.
Prevention and treatment of respiratory complications after surgery:
- Pulmonary atelectasis
Mechanism of action of erdomed
The mechanism of action is as an antioxidant and glycoprotein inhibitor.
Erdomed should always be used exactly as your doctor has instructed you.
- Children weighing between 15 and 19 kg: 5 ml of oral suspension, two times a day.
- Children weighing between 20 and 30 kg: 5 ml of oral suspension three times a day.
- Children weighing more than 30 kg and adults: 10 ml of oral suspension twice a day.
Form of administration
Preparation of the suspension: add water in the powder vial to the mark marked on the vial and shake vigorously; Fill the spot with water and shake again.
The vial should be shaken before each administration.
The usual dose of the capsule (300 mg of erdosteine) should be administered orally 2 to 3 times a day.
Side effects of erdomed
Rare cases of gastralgia, nausea, and vomiting have been reported after high doses (more than 1200 mg per day).
Hypersensitivity reactions (skin rash, urticaria, etc.) have been reported on rare occasions.
Warnings and Contraindications
Erdomed should not be administered if you have hypersensitivity to erdosteine or any excipients in the product or children weighing less than 15 kg.
Special care should be taken with the administration of erdomed in patients suffering from gastroduodenal ulcers.
It should be administered under medical supervision in patients with severe liver or kidney involvement.
This medicine contains aspartame (E 951). For being a source of phenylalanine. It can be harmful to people with conditions such as phenylketonuria.
In patients with homocystinuria, its use is not recommended due to the possible interaction of the metabolites with the metabolism of methionine and cysteine.
Because there are no clinical data available and it is not known whether the drug passes into breast milk, erdomed is not recommended during breastfeeding.
Although preclinical studies did not reveal embryotoxic, teratogenic, or mutagenic in the absence of clinical data, erdomed is not recommended during pregnancy.
No adverse effects that decrease the ability to drive vehicles or operate machinery have been reported.
This medicine contains sugar. If you are intolerant to some sugars, consult your doctor before taking domed.
Every 5 ml of oral suspension contains approximately 2 grams of sugar. This should be considered in patients who have diabetes.
As the volume of bronchial secretions increases, Erdomed can accentuate the cough reflex. Do not take medicine that suppresses cough, as sputum will not be able to be removed.
Even those purchased without a prescription, medications being taken should be reported to the physician.
Erdomed should not be administered with a cough suppressant because it can cause excessive accumulation of secretions due to inhibition of the cough reflex, resulting in stagnant secretions with a possible risk of bronchospasm and respiratory infections.
Erdosteine can be administered concomitantly with antibiotics such as amoxicillin, ampicillin, clarithromycin, ciprofloxacin, erythromycin, and bronchodilators such as bronchodilators salbutamol, or theophylline.